AHMEDABAD, India and NEW YORK, Nov. 26, 2025 /PRNewswire/ -- Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, today announced that it ...

Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...

NPPA asks Bayer Zydus Pharma to continue selling Urografin for one more year: Gireesh Babu, New Delhi Thursday, March 5, 2026, 08:00 Hrs [IST] The National Pharmaceutical Pricing ...

Shire Human Genetic Therapies and other plaintiffs filed a patent infringement lawsuit against Zydus Lifesciences Global FZE and its affiliated companies on Dec. 19 in Delaware District Court over ...

ChemoCentryx, a part of Amgen, filed a patent infringement lawsuit against Zydus Pharmaceuticals on Jan. 16 in New Jersey District Court over Zydus's attempt to market a generic version of Tavneos, a ...

Zydus Lifesciences and its wholly owned subsidiary, Zydus Lifesciences Global FZE, have entered into an exclusive licensing and supply agreement with Synthon BV of the Netherlands for ozanimod ...

Brokerage firm Choice Institutional Equities expects a mixed quarter for pharmaceutical companies in Q2 FY26, with domestic operations likely to outperform even as growth in the US moderates. The ...

Several Indian pharmaceutical companies including Glenmark, Granules India, Sun Pharma, Zydus and Unichem are recalling medicines from the US market, according to the US Food and Drug Administration ...

Saion Mukherjee, Managing Director & Head of Equity Research at Nomura says Indian pharmaceutical companies are preparing to ...

Bino Pathiparampil, Head of Research at Elara Securities believes the broader pharma space is entering a more favourable phase as pricing concerns and regulatory worries ease while currency movements ...

Ahmedabad: Zydus Lifesciences Limited has successfully completed the pivotal clinical development of its pembrolizumab biosimilar FYB206 and is preparing for a near-term Biologics ...